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ABSTRACT 
Because of concern that U.S. chronic hemodialysis patients are at high risk for the 
development of vitamin deficiencies, the great majority of such patients are routinely 
supplemented with a multivitamin.  This policy is supported by major U.S. dialysis 
providers and nonprofit organizations.  Yet routine multivitamin supplementation 
expands hemodialysis patients’ already large pill burden, probably accounts for many 
millions of dollars in annual costs, and in light of previous reports may even carry with it 
the possibility of increased risk of adverse outcomes.  An analysis of the benefits of 
routine multivitamin supplementation in U.S. patients is therefore in order.  We 
performed a systematic review of the medical literature between 1970 and 2014 using the 
Ovid Medline database to address this question.  We conclude that there is insufficient 
evidence to support routine multivitamin use and recommend that the decision to 
supplement be made on an individual basis. 
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INTRODUCTION 
Vitamins are organic nutrients required in small quantities for a variety of essential 
biochemical functions.  Vitamins are not usually synthesized by the body so must be 
supplied in the diet1.  Concern has existed for some time over the possibility that chronic 
hemodialysis patients are at high risk for the development of vitamin deficiencies because 
diets prescribed for kidney disease patients tend to be low in certain vitamins2, the 
dialysis procedure may result in clearance of vitamins from blood2,3, metabolites that 
accumulate in the uremic milieu may impair the proper utilization of vitamins2,3, 
spontaneous reductions in food intake due to uremia may lead to inadequate vitamin 
consumption3, and medications and/or illnesses common to hemodialysis patients may 
interfere with the absorption and/or activity of vitamins2-4.   
 
Because of such concerns hemodialysis patients in the U.S. are routinely prescribed 
multivitamin supplements.  In fact, over 70% of U.S. hemodialysis patients take such 
supplements, a far greater proportion than in other developed nations5.  Such a policy is 
officially promoted by large U.S. dialysis providers6,7 and nonprofit institutions8,9.  Yet 
the implications of this policy must be carefully considered.  While the total cost of 
hemodialysis vitamin supplementation in the U.S. is not available and probably accounts 
for a very small proportion of overall dialysis costs, it is likely to be in the many millions 
of dollars annually given the sizeable numbers of patients and available pricing10-12.  In 
addition, vitamin supplementation increases the already large pill burden hemodialysis 
patients must contend with.  Furthermore, in light of previous reports the possibility that 
vitamin supplementation may actually have harmful effects should be considered13-16.  
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Finally, US government-mandated fortification of foodstuffs may also mitigate the need 
to supplement certain vitamins.  
 
In light of questions about the potential benefits and drawbacks of vitamin 
supplementation and whether vitamin supplementation is beneficial, we performed a 
systematic review of the medical literature to evaluate the evidence for routine vitamin 
supplementation in the U.S. adult chronic intermittent hemodialysis population.  In this 
article we present the evidence for supplementing each individual vitamin.  We chose to 
focus exclusively on U.S. hemodialysis patients, the largest such population of any 
nationality, because their vitamin requirements may be unique in light of their food 
preferences and the specific pattern of vitamin fortification in U.S. foodstuffs. 
 
Systematic Review 
We limited our search to humans and the English language using the Ovid Medline 
database between 1970 and 2014 and search terms vitamins, avitaminosis, and dietary 
supplements and subheadings renal dialysis, hemofiltration, and hemodialysis.  From this 
database we used the separate terms of vitamin A, ascorbic acid, vitamin D, vitamin E, 
vitamin K, thiamine, riboflavin, niacinamide, vitamin B6, vitamin B12, biotin, folic acid 
and pantothenic acid.  Of the 1076 articles that were identified, we then focused primarily 
on studies of adult hemodialysis patients within the U.S., though we did examine and 
occasionally include data from other hemodialysis populations, especially if the literature 
was sparse on the topic.  We did not limit our initial search by patient age or location or 
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study design because of concerns about the paucity of published data on this topic and 
wanted to be certain to capture all relevant information prior to excluding any studies. 
 
What Defines Adequate Nutritional Intake? 
Adequacy of body content and functional activity of vitamins has been determined 
traditionally by assessing dietary intake, corresponding biochemical values––usually 
from serum or plasma or red blood cells, though occasionally in urine, and in enzyme 
activities--and other biological processes or clinical manifestations of deficiency or 
excess.  For example, the effects of certain vitamins on hemoglobin production or plasma 
and urinary oxalate levels may be indicators of deficiency or excess.  Though not ideal, 
the best available objective indicator of adequate vitamin intake is blood levels because 
correlating vitamin intake with illness has been much more elusive.  We will therefore 
use blood vitamin content as the basis of determining the need for vitamin 
supplementation.   
 
Dietary reference intakes (DRI) are a set of reference values that help establish daily 
nutrient intake recommendations and are therefore a standard by which the adequacy of 
nutrient intake can be assessed17.  While DRIs can be used as general benchmarks, 
extrapolating such benchmarks to patients with CKD or other illnesses in which they 
have not been carefully studied should be done with caution.  Table 1 summarizes 
recommended daily allowances (RDA) values for vitamins in healthy adult men and 
women and compares them with the content of several commercially available dialysis 
vitamin supplements.  RDA is the average daily intake level needed to meet the nutrient 
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requirements of nearly all (97-98%) healthy individuals.  As the table demonstrates, 
arguably the most commonly prescribed dialysis multivitamins contain only water 
soluble vitamins, including several at levels higher than the RDA.  
 
Current Recommendations on Dialysis Multivitamins 
The 2005 Kidney Disease Outcome Quality Initiative (KDOQI) guidelines state that “…it 
is prudent to supplement, rather than risk deficiency, especially when supplementation is 
safe at the recommended levels.  Therefore, dialysis patients are likely to benefit from 
daily vitamin supplementation that provides the recommended published vitamin profile 
for dialysis patients, with special attention…” given to B vitamins and folic acid18.  
Similar recommendations exist for children with chronic kidney disease, though this topic 
is not covered in this review19.   Kidney Disease Improving Global Outcomes (KDIGO) 
recommends only that patients with an elevated PTH be started on calcitriol or a vitamin 
D analog and that vitamin D deficiency be excluded and treated using the strategy for the 
general population20.  These recommendations are endorsed by the European Renal Best 
Practice (ERBP) guidelines21. 
 
WATER SOLUBLE VITAMINS 
Vitamin B1 (Thiamine) 
Thiamine is a cofactor for many enzymes involved in carbohydrate metabolism and 
neural function22.  Foods rich in thiamine include pork, legumes, beef, nuts, whole grains, 
and organ meat23 though for decades flour has been enriched with thiamine in the U.S.  
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Thiamine deficiency can result in beriberi and subsequent heart failure and peripheral 
neuritis 24.   
 
Evidence for Altered Requirements in Hemodialysis Patients 
Dialysis patients are theoretically at risk for thiamine deficiency because of poor 
nutritional intake and loss of water-soluble vitamins in the hemodialysis effluent24. 
However, studies examining thiamine blood content in hemodialysis patients report 
equivocal findings.  In the only study of U.S. patients, Ramirez et al demonstrated in the 
mid-1980s that 15 hemodialysis patients who were taken off their B vitamin 
supplementation were able to maintain normal thiamine blood levels over a six-month 
period. In five of those patients they measured thiamine directly pre- and post-HD and 
noted no significant change25.  A subsequent study reported normal thiamine blood levels 
(mean 162 ± 42 ng/ml; normal range: 92-224 mg/ml) in twenty German patients not on 
supplementation who had been on hemodialysis for a median of 24 months26.   
 
In contrast, several reports of modest size have described low thiamine blood levels in 
hemodialysis patients24,27-29.  Two of them—from Taiwan and Japan—reported an 
association between low thiamine levels and confusion or encephalopathy24,27, with one 
of them describing an unusually high prevalence (33%) of Wernicke Encephalopathy.  
An additional study in patients in an intensive care unit setting found that the initiation of 
continuous renal replacement therapy was associated with an acute but nonstatistically 
significant drop in plasma erythrocyte thiamine levels (382 ± 109 to 264 ± 136 nmol/L) 
over eight hours, though levels remained within the normal range (100-300nmol/L)30. 
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The lack of long term, contemporary data makes it difficult to assess the rate or risk of 
thiamine deficiency in U.S. hemodialysis patients.  Further complicating data 
interpretation is differences between nations in thiamine enrichment in flour and grains 
and their consumption.  It is not surprising that the reports of Wernicke Encephalopathy 
described above originated in Asian countries, where a combination of low thiamine 
enrichment31 and high carbohydrate consumption make this presentation more likely22.  
One would reasonably expect a much lower risk of thiamine deficiency--even among 
hemodialysis patients--in nations such as the U.S., which has very high levels of 
enrichment and consumption of flour products. 
 
Vitamin B2 (Riboflavin) 
Riboflavin is a hydrophilic B vitamin that is part of the moiety of flavin adenine 
dinucleotide (FAD) and flavin mononucleotide (FMN) that comprise flavoenzymes.  Its 
function involves metabolism of fats, carbohydrates and proteins23.  Riboflavin is found 
in milk and dairy products, meat, fish, eggs and broccoli.  In the U.S. breads and cereals 
have been enriched with riboflavin since the 1940s23.  Riboflavin deficiency is not fatal 
due to very efficient tissue conservation1 and is characterized by nonspecific symptoms 
and signs, though more advanced deficiency may involve cheilosis, desquamation and 
inflammation of the tongue, seborrheic dermatitis, and microcytic anemia22.   
 
Evidence for Altered Requirements in Hemodialysis Patients 
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There are currently no studies of riboflavin status in U.S. or other hemodialysis 
populations.  We expect that deficiency is less likely to occur in U.S. hemodialysis 
patients because of longstanding enrichment of foodstuffs with riboflavin. 
 
Vitamin B3 (Niacin)  
Niacin, ingested as either nicotinamide (from animal sources) or nicotinic acid (from 
plants), becomes active in vivo when converted to cofactors used for oxidative 
processes22.  Rich sources of niacin include baker’s yeast, animal and dairy products, 
cereals, legumes, and leafy green vegetables22.  Niacin can also be synthesized from the 
amino acid tryptophan.  Niacin deficiency leads to pellagra, characterized by the “4 Ds”: 
dermatitis, diarrhea, dementia, and death.  Pellagra is typically observed with intakes 
deficient in niacin and tryptophan, such as maize-based diets22.   
 
Evidence for Altered Requirements in Hemodialysis Patients 
Fifteen American hemodialysis patients dialyzed using parallel-plate dialyzers were able 
to sustain normal niacin levels for 6 months after being taken off vitamin 
supplementation25.  An additional study in Japanese patients on hemodialysis for a mean 
of 7 years found mean blood nicotinamide adenine dinucleotide (NAD) levels to be no 
different from controls not on hemodialysis32.  There is inadequate data to definitively 
assess the risk of niacin deficiency in U.S. hemodialysis patients, but current fortification 
of foodstuffs with niacin makes it less likely to occur. 
 
Vitamin B5 (Pantothenic Acid) 
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Pantothenic acid is used to synthesize Coenzyme A (CoA), a critical factor in many 
metabolic processes including fatty acid oxidation, protein transport, and the formation of 
acetyl CoA, a key molecule in energy metabolism23.  Although pantothenic acid appears 
to be ubiquitous in the food supply, whole grains, vegetables, liver, and egg yolks are 
especially rich sources23.  Deficiency has not been clearly identified in humans except in 
specific depletion studies.   
 
Evidence for Altered Requirements in Hemodialysis Patients 
No data exists on this topic. 
 
Vitamin B6 (Pyridoxine) 
Vitamin B6 exists in vivo in several forms: pyridoxal, pyridoxine, pyridoxamine, and the 
5’ phosphates of these compounds.  Pyridoxal-5-phosphate (PLP) is a cofactor for many 
enzymes, particularly those involving amino acid metabolism, and is necessary for heme 
synthesis3.  Vitamin B6 is generally abundant in foods but especially rich sources include 
meats, whole grain products, vegetables, and nuts22.  Severe vitamin B6 deficiency may 
lead to peripheral neuropathy, convulsions, dermatitis, abnormal electrocardiogram 
findings, depression, confusion and due to its involvement with hemoglobin synthesis, 
microcytic anemia22,23.  Interestingly, sensory neuropathy has been reported in patients 
taking daily doses of B6 as low as 200 mg, with residual damage remaining after stopping 
supplementation1.   
 
Evidence for Altered Requirements in Hemodialysis Patients 
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A systematic review of the international literature estimated that between 24 and 56% of 
all hemodialysis patients have vitamin B6 deficiency33, while a 1981 study using an older 
assay reported that levels were lower in dialysis patients versus healthy Americans34.  If 
true, part of the explanation may lie in the plasma clearance of vitamin B6 during dialysis, 
which was reported to be between 28 and 48% depending upon the dialyzer used35, with 
cellulose triacetate high-flux/high-efficiency (HF/HE) dialysis membranes clearing 
vitamin B6 to a much greater extent than cuprophane membranes36.   Similarly, 
continuous renal replacement therapy has been noted to clear PLP by a mean of 0.02 
mg/day35.  However, the assertion that pyridoxine is cleared by hemodialysis has been 
challenged in a more recent study37.  While greater clearance of vitamin B6 heightens the 
risk of deficiency, an older study found that U.S. hemodialysis patients taken off B6 
vitamin supplementation were able to maintain stable levels within the normal range for 
the six month study period25.  Additional and more recent studies have confirmed that 
U.S. hemodialysis patients have PLP levels within the normal range38,39. 
 
While vitamin B6 may possibly be cleared from plasma during hemodialysis, there exists 
no clear evidence that stable U.S. hemodialysis patients are at appreciable risk for 
vitamin B6 deficiency. 
 
Vitamin B7 (Biotin) 
Biotin helps mediate carboxylation and cell cycle regulation by biotinylating key nuclear 
proteins1.  Biotin is widely distributed in many foods as biocytin (-amino-biotinyllysine), 
which is released with proteolysis.  It is also synthesized by intestinal flora in excess of 
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requirements1.  Though deficiency is rare it can occur with prolonged total parental 
nutrition or massive consumption of egg white, which contains avidin, which binds biotin 
in the intestine.  Deficiency results in mental status changes, paresthesias, and nausea23. 
 
Evidence for Altered Requirements in Hemodialysis Patients 
There are no studies of biotin status in US hemodialysis patients.  In a study by Oguma et 
al, 27 Japanese HD patients found that biotin levels were significantly higher than 
controls, but the assay used may have been measuring biotin and its metabolites40. 
 
Vitamin B9 (Folic Acid) 
Folic acid transports single carbons or methyl groups to help synthesize nucleotides 
needed for cell division and growth22.  It is also needed for the metabolism of several 
amino acids3.  Food sources rich in folic acid include leafy green vegetables, fruit, yeast, 
and liver22.  Nationwide fortification of cereal grains in the United States and Canada 
began in 199641.  Deficiency results in megaloblastic anemia and neural tube defects.  Of 
note, initial support for supplementing hemodialysis patients with folic acid, vitamin B6, 
and vitamin B12 was partly related to their ability to lower the putative atherothrombotic 
risk factor plasma homocysteine.  The rationale for such a strategy has dissipated now 
that homocysteine lowering has been demonstrated not to have cardioprotective effects42. 
 
Evidence for Altered Requirements in Hemodialysis Patients 
While the risk of folic acid deficiency may be higher in HD patients because leafy green 
vegetables tend to be restricted due to high potassium content, this is likely offset by the 
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fortification of grains and cereals in the U.S.43  A series of older and contemporary U.S. 
studies including many hundreds of patients, pre- and post-fortification, report that folate 
levels are well maintained in chronic hemodialysis patients25,38,39,44-46.  Based on the 
available evidence, it appears that folic acid deficiency is very uncommon among U.S. 
chronic hemodialysis patients. 
 
Vitamin B12 (Cyanocobalamin) 
Vitamin B12 plays a major role in the methylation cycle and is a cofactor in the synthesis 
of the amino acid methionine22.  Major food sources are those of animal origin like eggs, 
liver, beef, chicken and salmon because with rare exception it is only synthesized by 
bacteria found in higher predatory organisms and not plant foods1.  Vitamin B12 is also 
found in fortified foods like breakfast cereals3.  Vitamin B12 deficiency causes a 
functional folate and methionine deficiency leading to megaloblastic anemia and 
irreversible degeneration of the spinal cord (i.e. pernicious anemia)1.  Vitamin B12 can be 
measured directly in serum or plasma, though methylmalonic acid levels is a more 
specific and sometimes more sensitive indicator of vitamin B12 deficiency22. 
 
Evidence for Altered Requirements in Hemodialysis Patients 
In a study of fifteen U.S. hemodialysis patients, B12 levels remained in the normal range 
during a six-month study period despite not taking B vitamin supplementation25.  
Multiple additional studies have demonstrated that U.S. hemodialysis patients have 
normal B12 levels38,39,45,46 and are not at high risk of vitamin B12 deficiency.  
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Vitamin C (Ascorbic Acid) 
While the main function of Vitamin C is to maintain collagen function, it also acts as an 
electron donor and cofactor in the production of catecholamines, many peptide hormones, 
osteocalcin, C1q (part of the complement cascade), protein C, and carnitine1,22.  Major 
sources include green vegetables, citrus fruits, potatoes and tomatoes23.  Vitamin C 
deficiency causes scurvy which manifests as tooth loss, gum decay, fragility of 
capillaries, bone fractures and skin changes1.   
 
Evidence for Altered Requirements in Hemodialysis Patients 
Achieving optimal vitamin C status is a challenge in hemodialysis patients.  Renal dietary 
restrictions imposed on such patients make it more likely they will avoid foods with high 
vitamin C content.  Additionally, vitamin C is cleared during standard hemodialysis 
sessions47-49.  However, vitamin C supplementation contributes to a rise in oxalate47 
which can deposit in tissues and lead to bone disease, arthropathies, vascular 
calcification, skin deposits, and liver failure50. 
  
The only study in U.S. patients was performed over twenty years ago and demonstrated 
that white and black hemodialysis patients—most of whom took a daily vitamin C-
containing multivitamin--had similar and normal mean vitamin C plasma 
concentrations51.  Several other reports from Europe and Asia report a relatively high 
prevalence of vitamin C deficiency, though the whether this led to detrimental effects was 
not well described47,48,52-54.  Oral and/or intravenous vitamin C supplementation have 
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been shown in hemodialysis patients to increase vitamin C blood levels with relative 
ease47,48,53,54.   
 
The available medical literature is not helpful in ascertaining the risk of vitamin C 
deficiency in US hemodialysis patients, though theoretical concerns cited above remain.  
This must be balanced by contrary concerns about oxalate deposition and end-organ 
damage from vitamin C supplementation and the lack of reports of vitamin C deficiency 
in countries that do not use vitamin supplementation.   
 
FAT SOLUBLE VITAMINS 
Vitamin A 
Vitamin A plays an important role in the proper function of the visual and immune 
system, cell differentiation, and cell turnover1,22.  Carotenoids, which are precursors to 
vitamin A, are abundant in dark green and deeply colored fruits and vegetables23, while 
preformed vitamin A is present in animal source foods like liver, fish, and eggs22.  
Vitamin A deficiency results in night blindness and xerophthalmia and is the leading 
cause of preventable blindness in children22.  It also decreases normal function of vitamin 
D and increases susceptibility to infection1 by compromising the innate and acquired 
immune system 23.  
 
Evidence for Altered Requirements in Hemodialysis Patients 
While there are no studies of vitamin A in the U.S. hemodialysis population, studies from 
Europe and Australia55-59 reported that vitamin A levels in chronic hemodialysis patients 
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were generally within the normal range and frequently at least as high, if not higher, than 
healthy controls.  
 
Vitamin E 
Vitamin E influences the fluidity of cell membranes and prevents oxidative damage by 
reacting with lipid peroxide radicals1.  Because vitamin E is widely dispersed in foods 
and oils deficiency is uncommon though can occur with diseases like cystic fibrosis or 
other diseases associated with fat malabsorption23.  Vitamin E deficiency is associated 
with nerve and muscle damage, opthalmoplegia, pigmented retinopathy and hemolytic 
anemia1,23.   
 
Evidence for Altered Requirements in Hemodialysis Patients 
A recent study of eleven U.S. hemodialysis patients found that baseline levels were 
within the normal range and increased significantly with vitamin E supplementation60.  
These findings have been replicated in several other studies performed outside the 
US55,57,61,62, though not all concur58. 
 
Vitamin K 
Vitamin K is a critical cofactor for the clotting system and nervous system development1.  
Vitamin K is found in two forms: phylloquinone (PK) (vitamin K1), found in green leafy 
vegetables and animal products, and menaquinone (MK) (vitamin K2), which is 
synthesized by intestinal bacteria.  Sources of vitamin K include kale, spinach, liver, 
margarine, vegetable oils, and soybean oils23.  Vitamin K deficiency is caused by low 
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dietary intake, chronic liver disease, and conditions that alter intestinal flora or fat content 
of bile salts.  Prolonged prothrombin time is the most common and earliest finding of 
deficiency and is associated with increased bleeding risk from inactivation of vitamin K-
dependent clotting factors23. 
 
Evidence for Altered Requirements in Hemodialysis Patients 
There are no studies of vitamin K in US hemodialysis patients.  Several European studies 
reported that mean vitamin K levels of hemodialysis patients were normal63-65, though a 
minority of subjects did have low levels65, as did subjects in a separate study that 
indirectly measured vitamin K status as reflected in protein carboxylation66.  The clinical 
implications of this are unknown. 
 
Vitamin D 
Vitamin D is found in several forms: D2 from plant sources (ergocalciferol) and vitamin 
D3 (cholecalciferol) from animal sources.  Both D2 and D3 undergo hydroxylation to 
form 25-hydroxy (calcidiol) and 1,25-hydroxyvitamin D (calcitriol), the active forms of 
vitamin D.  Vitamin D functions to maintain calcium homeostasis23 though it is under 
investigation for additional effects.  Vitamin D is abundant in fish and its oil.  Risk 
factors for deficiency include old age, dark skin, lack of sun exposure, obesity and fat 
malabsorption.  Deficiency is manifested by muscle soreness, weakness and bone pain23, 
leading to rickets in children and osteomalacia in adults1.   
 
Evidence for Altered Requirements in Hemodialysis Patients 
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Kidney failure is known to lead to inadequate production of calcitriol and secondary 
hyperparathyroidism, which is why calcitriol or its analogues are routinely supplemented 
in hemodialysis patients.  The more pertinent question is whether the earlier forms of 
vitamin D (i.e. D2, D3, calcidiol) are needed for supplementation.  Indeed, a cross-
sectional analysis of 825 U.S. hemodialysis patients demonstrated that calcidiol 
deficiency is widely prevalent 67.  However, the benefits of D2, D3 or calcidiol 
supplementation are unknown68-70.  Of note, recommended doses used to treat vitamin 
deficiency are far higher than what is usually contained in standard multivitamin 
tablets68. 
 
ASSESSMENT OF THE LITERATURE AND RECOMMENDATIONS 
Hemodialysis patients are prescribed multivitamins for an increased theoretical risk of 
(primarily water soluble) vitamin deficiencies.  As our review indicates, the available 
information does not strongly support routine water-soluble vitamin supplementation.  
With regard to fat-soluble vitamins, only vitamin D has been consistently demonstrated 
to be low in a significant segment of U.S. hemodialysis patients, and a daily multivitamin 
therapy is not appropriate treatment for this deficiency because supplementation 
recommendations require much higher doses. 
 
In light of our findings we advise against a blanket recommendation to supplement all 
hemodialysis patients and recommend instead that supplementation be individualized 
based on clinical judgment and necessity.  Reasons include the lack of supportive 
evidence as well as the associated inconvenience, cost, and possibly even hazards of 
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consuming a daily dialysis vitamin.  The latter concern is rarely cited but should not be 
ignored.  There is epidemiologic and clinical trial data supporting an increased risk of 
cardiovascular events in men taking supplemental calcium13, of advanced and fatal 
prostate cancers in healthy men14 and transaminitis in HIV patients16 with multivitamin 
use, and of mortality in lung cancer patients taking beta carotene and vitamin A15.  Apart 
from the risks, the literature is littered with negative clinical trials studying 
multivitamins71-76.  Thus, we should not automatically assume that multivitamin therapy 
is not without risks.  Rather, primum non nocere should be our code of action.  
 
Of note, a recent epidemiologic analysis from the international Dialysis Outcomes and 
Practice Patterns Study (DOPPS)77 observed that greater use of water soluble vitamin 
supplementation was associated with lower mortality rates.  We would urge caution in 
accepting this finding in light of the study’s limitations, which include lack of face-to-
face confirmation that supplements were or were not being used, lack of direct 
measurements of blood vitamin levels, limitations in the variables accounted for in the 
final statistical model, and the interesting observation that vitamin supplementation is 
nearly existent in countries with much lower mortality rates like Japan.   
 
We do recognize that the medical literature on this topic is limited and that existing 
studies in U.S. patients are typically small or may reflect outdated dietary or societal 
fortification patterns or dialysis technology.  We also understand that there exists a 
subgroup of hemodialysis patients who are clearly at risk for vitamin deficiencies.  This 
is why we advocate for individualization of multivitamin use.  Specific conditions that 
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would argue for vitamin supplementation include pregnancy78, gastric bypass surgery79, 
anorexia with poor food intake80, vegetarian diet or malabsorption states81,82, and the use 
of certain medications83,84.  Finally, our findings should not automatically be extrapolated 
to hemodialysis populations outside the U.S., which have different dietary intake patterns 
and exposure to vitamin fortification in foodstuffs. 
 
In summary, a review of the literature offers no strong evidence arguing for routine 
multivitamin supplementation in U.S. chronic hemodialysis patients.  In light of the 
potential benefits and risks of dialysis vitamin use, we recommend that supplementation 
be individualized based on each patient’s needs and risk profile.  Further study of this 
topic using adequately powered and well-designed trials would be in order.  
 
PRACTICAL APPLICATION 
Multivitamin supplements are commonly provided to hemodialysis patients in the United 
States.  We systematically reviewed the literature and found no strong evidence for 
routine supplementation.  We argue that supplementation should be individualized 
according to each patient’s needs. 
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Table 1:  Comparison of Recommended Daily Allowances and the Content of Common 
Dialysis Multivitamin Supplements 
 
 Adult Male 
DRI  
Adult Female 
DRI 
Nephrocaps85 Nephrovite86 Dailyvite11 
Vitamin A (mcg)  900 700 -- -- -- 
Vitamin C (mg) 90 75 100 60 100 
Vitamin D (mcg) a,b 15  
(20 if > 70 yr) 
15  
(20 if > 70 y) 
-- -- -- 
Vitamin E (mg)  15 15 -- -- -- 
Vitamin K (mcg) 120 90 -- -- -- 
Thiamin (mg) 1.2 1.1 1.5 1.5 1.5 
Riboflavin (mg) 1.3 1.1 1.7 1.7 1.7 
Niacin (mg)  16 14 20 20 20 
Vitamin B6 (mg) 1.7 
(≥51 yr) 
1.5 
(≥51 yr) 
 
10 0.006 10 
Folate (mcg)  400 400 1000 1000 1000 
Vitamin B12 (mcg) 2.4 2.4 6 6 6 
Pantothenic Acid 
(mg) 
5 5 5 10 10 
Biotin (mcg) 30 30 150 300 300 
Choline (mg)  550 425 -- -- -- 
